hide all-
Craig Barbarosh
-
Mr. Barbarosh has been a partner of the international law firm of Pillsbury Winthrop Shaw Pittman LLP since 1999. Mr. Barbarosh is a nationally recognized restructuring expert and has served in several leadership positions while a partner at Pillsbury including serving on the firm's Board of Directors, as the Chair of the firm's Board's Strategy Committee, as a co-leader of the firm's national Insolvency & Restructuring practice section and as the Managing Partner of the firm's Orange County office. Mr. Barbarosh received a Juris Doctorate from the University of the Pacific, McGeorge School of Law in 1992 and a Bachelor of Arts in Business Economics from the University of California at Santa Barbara in 1989. In 2007, Mr. Barbarosh received a certificate from Harvard Business School for completing an executive education course on Private Equity and Venture Capital.
Holdings: 3,396 shares
View Transactions
Date Type Shares Traded Price Range Aug 11, 2010 Acquisition (Non Open Market) 1,250 n/a Jan 27, 2010 Acquisition (Non Open Market) 1,146 59.55 Nov 3, 2009 Buy 1,000 59.45 -
Murray Brennan
-
Dr. Murray Brennan is Emeritus Chairman of the Memorial Sloan-Kettering Cancer Center's Department of Surgery and previously served as Chairman from 1985 to 2007. Dr. Brennan has lectured and been a visiting professor throughout the world and has authored more than 1000 scientific papers. He has served as director of the American Board of Surgery, Chairman of the American College of Surgeons Commission on Cancer, President of the Society of Surgical Oncology, President of the American Surgical Association, the oldest and most prestigious surgical association in the United States, and Vice President of the American College of Surgeons. Dr. Brennan is a member of the Institute of Medicine of the National Academy of Sciences. He is the recipient of numerous honors and medals for his leadership of surgery and oncology worldwide. Dr. Brennan currently serves on the Board of Directors of Ziopharm Oncology, Inc., a publicly-held biopharmaceutical company engaged in the development and commercialization of a diverse, portfolio of cancer drugs to address unmet medical needs. Dr. Brennan also serves on the Board of Directors of the de Beaumont Foundation.
Holdings: 3,000 shares
View Transactions
Date Type Shares Traded Price Range Aug 11, 2010 Acquisition (Non Open Market) 1,000 n/a Nov 4, 2009 Buy 1,000 60.25 Aug 13, 2009 Acquisition (Non Open Market) 1,000 n/a -
George Bristol
-
George H. Bristol is a director. Mr. Bristol is an independent financial consultant. From August 2006 until March 2010 he served as Managing Director – Corporate Finance of Crowell Weedon & Co. Prior to August 2006, he was a member and Chief Financial Officer of Vantis Capital Management, LLC, a registered investment advisor which managed the Vantis hedge funds totaling over $1.4 billion from November 2002. Prior to Vantis, he was an investment banker with several firms including Ernst & Young, Paine Webber, Prudential Securities and Dean Witter. He is a graduate of the University of Michigan and Harvard Business School. Mr. Bristol has been a director of our company since 2008. Mr. Bristol's experience at Vantis and his various corporate finance positions provides our Board with insight from someone with direct responsibility for strategic and transactional financial matters.
Holdings: 3,500 shares
View Transactions
Date Type Shares Traded Price Range Aug 11, 2010 Acquisition (Non Open Market) 1,250 n/a Aug 28, 2009 Acquisition (Non Open Market) 1,000 54.00 Aug 13, 2009 Acquisition (Non Open Market) 1,250 n/a -
Patrick B. Cline
-
Patrick B. Cline currently serves as President. He served as the Company's interim Chief Executive Officer for the April - July 2000 period. Mr. Cline was a co-founder of Clinitec; a company acquired by Quality Systems, Inc. in 1996, and has served as its President since its inception in January 1994 and throughout its transition to NextGen Healthcare Information Systems. Prior to co-founding Clinitec, Mr. Cline served, from July 1987 to January 1994, as Vice President of Sales and Marketing with Script Systems, a subsidiary of InfoMed, a healthcare information systems company. From January 1994 to May 1994, after the founding of Clinitec, Mr. Cline continued to serve, on a part time basis, as Script Systems' Vice President of Sales and Marketing. Mr. Cline has held senior positions in the healthcare information systems industry since 1981. Mr. Cline was appointed a director of the Company by the Board on May 25, 2005.
Holdings: 13,750 shares
View Transactions
Date Type Shares Traded Price Range May 1, 2009 Option Execute 13,750 38.83 Apr 29, 2009 Sell 42,500 54.00 - 54.10 Apr 29, 2009 Option Execute 42,500 19.34 Aug 13, 2008 Sell 143,000 39.50 - 39.85 Aug 13, 2008 Option Execute 91,500 3.87 - 19.34 -
Ahmed Hussein
-
Ahmed Hussein is, and has been since 1997, the Director of National Investment Company, Cairo, Egypt. Mr. Hussein founded National Investment Company in 1996 and has served as a member of its Board of Directors since its inception. Mr. Hussein served as a Senior Vice President of Dean Witter from1993 to 1996. Mr. Hussein is a director of the following publicly held Egyptian companies: Simo Paper Company and Nobria Agriculture.
Holdings: 4,619,600 shares
View Transactions
Date Type Shares Traded Price Range Aug 11, 2010 Acquisition (Non Open Market) 1,000 n/a Sep 18, 2009 Option Execute 10,000 12.75 Aug 13, 2009 Acquisition (Non Open Market) 1,000 n/a -
Russell Pflueger
-
Russell Pflueger is and has been since 2002 the Founder, Chairman and CEO of Quiescence Medical, Inc., a medical device development company. During 2001 and 2002, he founded and served as Chairman and CEO of Pain Concepts, Inc., a medical device company. He holds a Chemical Engineering degree from Texas A&M University and a Master of Business Administration degree from the University of California at Irvine.
Holdings: 4,500 shares
View Transactions
Date Type Shares Traded Price Range Aug 11, 2010 Acquisition (Non Open Market) 1,250 n/a Sep 15, 2009 Buy 2,000 56.95 - 56.95 Aug 13, 2009 Acquisition (Non Open Market) 1,250 n/a -
Steven T. Plochocki
-
Mr. Plochocki serves as Chief Executive Officer of the Company. He has been a director of the Company since 2004. From February 2007 to May 2008, he served as Chairman and Chief Executive Officer of Omniflight Helicopter, Inc., a Dallas-based air medical services company. He previously served as Chief Executive Officer and Director of Trinity Hospice, a national hospice provider from October 2004 through October 2006. Prior to joining Trinity Hospice, he was Chief Executive Officer of InSight, a national provider of diagnostic imaging services from November 1999 to August 2004. Prior to that, he was Chief Executive Officer of Centratex Support Services, Inc., a support services company for the healthcare industry and had previously held other senior level positions with healthcare industry firms. He holds B.A. in Journalism and Public Relations from Wayne State University and a Master's degree in Business Management from Central Michigan University.
Holdings: 2,000 shares
View Transactions
Date Type Shares Traded Price Range Jun 7, 2010 Buy 2,000 55.61 Sep 11, 2008 Sell 29,998 43.20 - 45.62 Sep 11, 2008 Option Execute 45,250 12.75 - 39.81 Sep 11, 2008 Sell 15,252 43.00 - 45.60 -
Sheldon Razin
-
Sheldon Razin is the founder of the Company and has served as its Chairman of the Board since the Company's inception in 1974. He served as the Company's Chief Executive Officer from 1974 until April 2000. Since its inception until April 2000, he has also served as the Company's President, except for the period from August 1990 to August 1991. Additionally, Mr. Razin served as Treasurer from the Company's inception until October 1982. Prior to founding the Company, he held various technical and managerial positions with Rockwell International Corporation and was a founder of the Company's predecessor, Quality Systems, a sole proprietorship engaged in the development of software for commercial and space applications and in management consulting work. Mr. Razin holds a B.S. degree in Mathematics from the Massachusetts Institute of Technology.
Holdings: 5,057,380 shares
View Transactions
Date Type Shares Traded Price Range Aug 11, 2010 Acquisition (Non Open Market) 1,250 n/a Aug 21, 2009 Option Execute 10,000 12.75 Aug 13, 2009 Acquisition (Non Open Market) 1,250 n/a -
Maureen Spivack
-